Sign in to view content

Assessing Characteristics of Patients With or Without Intraocular Inflammation (IOI) In the Brolucizumab Treatment Arms From the HAWK and HARRIER, Phase 3 Studies

Jeffrey S. Heier, MD

Video
Published 2020

Related

Results from Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity
Rishi P. Singh, MD
Updates from the Field
2024
Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process
Raj K. Maturi, MD
Updates from the Field
2019
SLE Retinopathy
Mitzy E Torres Soriano, MD
Federico Furno Sola, MD
Retina Image Bank: Images of the Week
2016

Category: Age-Related Macular Degeneration

See more